Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Insulin Resistance 5Hyperglycemia 3Polycystic Ovary Syndrome 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oligomenorrhea 1Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Intracranial Aneurysm 1Hypoglycemia 1Hyperphagia 1Hyperinsulinism 1Hyperandrogenism 1Hirsutism 1Diabetes Mellitus, Type 2 1Diabetes Mellitus, Type 1 1Congenital Abnormalities 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Insulin × Clear all
NCT05010356 2021-08-18

Insulin Sensitivity After Breast Cancer

University of Copenhagen

Phase NA Recruiting
24 enrolled
Breast

Breast Neoplasms, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡